Adherence to Preventive Care for Cervical Cancer

NCT ID: NCT02406391

Last Updated: 2015-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-04-30

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the United States, the highest incidence of cervical cancer occurs in inner city urban centers, rural areas, the deep South, Appalachia and the U.S.-Mexico border. The goal of this study is to study predictors of adherence among patients seeking care at an inner city medical center in New York City and the U.S. Mexico border for cervical cancer prevention, namely, Pap smears and colposcopy exams.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Because there are multiple pathways through which a person is influenced to seek and receive care, the investigators will conduct interviews with patients seeking care for cervical cancer prevention at an inner city medical center. The investigators will ask questions related to previous screening, diagnostic, and treatment practices as well as barriers experienced in seeking such care. The investigators will also explore patients' level of resiliency and coping as predictors of adherence to timely care. Furthermore, among immigrants, questions about acculturation and discrimination will be asked. Additional measures of socioeconomic status, such as education, income and occupation will also be collected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Cancer Cervical Precancer Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women who are at least 21 years old
* are seeking care for a Pap smear exam
* are seeking care for a colposcopy exam for the first time
* are not pregnant by self-report
* are able to provide informed consent

Exclusion Criteria

* women who do not meet the above eligibility criteria
* women who have no prior history of a hysterectomy
* women who have previously participated in this study
Minimum Eligible Age

21 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brookdale University Hospital Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michele Follen

Chair of Department of Obstetrics and Gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michele Follen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Brookdale University Hospital and Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brookdale University Hospital and Medical Center

Brooklyn, New York, United States

Site Status

University of Texas at El Paso

El Paso, Texas, United States

Site Status

Texas Tech University Health Science Center

El Paso, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Leonid Fradkin, PhD

Role: CONTACT

718-240-8225

Thelma Carrillo

Role: CONTACT

718-240-5978

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Leonid Fradkin, PhD

Role: primary

718-240-8225

Thelma Carrillo, MPH

Role: backup

718-240-5978

Christina M Gutierrez, MS

Role: primary

915-215-5103

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.